| ADR Ontology |
| ADR Term |
Superior vena cava syndrome |
| ADR ID |
BADD_A04203 |
| ADR Hierarchy |
|
| Description |
A disorder characterized by obstruction of the blood flow in the superior vena cava. Signs and symptoms include swelling and cyanosis of the face, neck, and upper arms, cough, orthopnea and headache. [CTCAE] A condition that occurs when the obstruction of the thin-walled SUPERIOR VENA CAVA interrupts blood flow from the head, upper extremities, and thorax to the RIGHT ATRIUM. Obstruction can be caused by NEOPLASMS; THROMBOSIS; ANEURYSM; or external compression. The syndrome is characterized by swelling and/or CYANOSIS of the face, neck, and upper arms. [MeSH] |
| MedDRA Code |
10042569 |
| MeSH ID |
D013479
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
|
| Synonym |
| Superior vena cava syndrome | Superior Vena Cava Syndrome | Superior Vena Cava Obstruction | Superior Vena Cava Thrombosis |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
